LH logo

LH Stock Overview

Profile

Full Name:

Labcorp Holdings Inc.

Sector:

Healthcare

Industry:

Diagnostics & Research

Country:

United States

IPO:

March 29, 1990

Indexes:

S&P 500

Website:

http://www.labcorp.com

Description:

Laboratory Corporation of America Holdings is a global company in the field of natural sciences. It provides comprehensive clinical laboratory services and drug development services through its LabCorp Diagnostics (LCD) and Covance Drug Development (CDD) segments. The company was founded in 1971, headquartered in Burlington, North Carolina. LabCorp provides diagnostic, drug, and technology solutions for more than 160 million clients per year, or over 3 million per week. The company also supports clinical trials in approximately 100 countries through its industry-leading central laboratories, preclinical and clinical development, generating more safety and efficacy data to support drug approvals than any other company.

Key Details

Price

$252.87

Market Cap

$21.09 B(Large cap)

Last Dividend

$0.72

TTM Dividend Yield

1.14%

Annual Revenue

$13.01 B(+6.97% YoY)

Annual EPS

$8.84(+85.32% YoY)

PE Ratio

28.67

Annual ROE

9.35%

Annual Debt To Equity

0.79

Beta

0.42

Events Calendar

Earnings

Next earnings date:

Apr 25, 2025

Recent quarterly earnings:

Feb 6, 2025

Recent annual earnings:

Feb 6, 2025
Dividend

Next ex-dividend date:

Feb 27, 2025

Recent ex-dividend date:

Nov 26, 2024
Splits

Next split:

N/A

Recent split:

Jul 3, 2023

Analyst ratings

Recent major analysts updates

Feb 10, 25 Piper Sandler
Neutral
Feb 7, 25 Barclays
Equal-Weight
Feb 6, 25 Jefferies
Buy
Feb 3, 25 Barclays
Equal-Weight
Jan 28, 25 UBS
Buy
Jan 7, 25 Evercore ISI Group
Outperform
Dec 17, 24 Morgan Stanley
Overweight
Dec 13, 24 B of A Securities
Buy
Dec 10, 24 Jefferies
Buy
Oct 30, 24 HSBC
Buy

Screeners with LH included

US stocks
High Piotroski score stocks
S&P 500 companies earnings calendar
Most recommended stocks
Best performing stocks last 3 months
Best performing stocks last 5 years
Stocks above SMA 50
S&P 500 companies
Stocks below analysts price target
S&P 500 companies dividend calendar

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$252.87
LH price is $252.87

Price All-time High

$269.94
LH price is currently -6.32% below its historical high of $269.94

Price Analysts Target

$270.00
LH price is currently -6.34% lower than the consensus analysts' forecast

Price Most Recent Change

+0.57%
LH price was up +0.57% on Feb 25, 2025

Price YTD Change

+10.71%
LH price is up +10.71% since January 1st

Price 3-Year Change

+6.4%
LH price is up +6.4% over the past 3 years

Market cap

Market Cap

$21.09 B
LH market capitalization is $21.09 billion

Market Cap 3-Year Change

-4.99%
LH market capitalization is down -4.99% over the past 3 years

Market Cap All-time High

$25.76 B
LH market capitalization is currently -18.14% below its historical high of $25.76 billion

Market Cap Sector Rank

95.53%
LH market capitalization is higher than 95.53% of companies in Healthcare sector

Technical

Beta

0.42
LH beta is 0.42

200-day SMA

$223.91
LH price is currently +12.94% above its 200-day simple moving average

14-day RSI

65.80
LH 14-day relative strength index is 65.80

30-day Relative Volume

0.89
LH 30-day relative volume is 0.89

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.72
LH last dividend was $0.72 per share, with an ex-dividend date of November 26, 2024

Next Dividend

$0.72
LH has announced a dividend of $0.72 per share, with an ex-dividend date set for February 27, 2025

Dividend per share

Annual Dividend Per Share

$2.88
LH annual dividend per share is $2.88

Annual Dividend Per Share Sector Rank

81.48%
LH annual dividend per share is higher than 81.48% of companies in Healthcare sector

Annual Dividend Per Share 1-Year Change

0%
LH {parameterFullLabel} has remained unchanged year-on-year

Annual Dividend Per Share 3-Year Change

+260%
LH annual dividend per share is up +260% over the past 3 years

Dividend yield

Annual Dividend Yield

1.14%
LH annual dividend yield is 1.14%

Annual Dividend Yield Sector Rank

35%
LH annual dividend yield is higher than 35% of companies in Healthcare sector

Other

Annual Payout Ratio

32.59%
LH annual payout ratio is 32.59%

Annual Dividends Paid

$243.10 M
LH annual dividends paid is $243.10 million

Annual FCF

$1.10 B
LH annual free cash flow is $1.10 billion

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$13.01 B
LH annual revenue is $13.01 billion

Annual Revenue Analysts Estimate

$13.92 B
LH annual revenue is currently -6.58% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

+6.97%
LH annual revenue is up +6.97% year-on-year

Annual Revenue Sector Rank

95.2%
LH annual revenue is higher than 95.2% of companies in Healthcare sector

Profit

Annual Gross Profit

$3.62 B
LH annual gross profit is $3.62 billion

Annual Gross Margin

27.86%
LH annual gross profit margin is 27.86%

Annual Operating Profit

$1.14 B
LH annual operating income is $1.14 billion

Annual Operating Margin

8.75%
LH annual operating profit margin is 8.75%

Annual Net Income

$746.00 M
LH annual net profit is $746.00 million

Annual Net Margin

5.73%
LH annual net profit margin is 5.73%

EPS

Annual EPS

$8.84
LH annual earnings per share is $8.84

Annual EPS Analysts Estimate

$16.03
LH annual earnings per share is currently -44.85% lower than the consensus analysts' forecast

Annual EPS 1-Year Change

+85.32%
LH annual earnings per share is up +85.32% year-on-year

Annual EPS Sector Rank

98.05%
LH annual earnings per share is higher than 98.05% of companies in Healthcare sector

ROA & ROE

Annual ROA

4.25%
LH annual return on assets is 4.25%

Annual ROE

9.35%
LH annual return on equity is 9.35%

EBIT & EBITDA

Annual EBIT

$1.17 B
LH annual earnings before interest & taxes is $1.17 billion

Annual EBITDA

$1.81 B
LH annual EBITDA is $1.81 billion

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

28.67
LH price to earnings ratio is 28.67

PE Ratio Sector Rank

52.55%
LH price to earnings ratio is higher than 52.55% of companies in Healthcare sector

PB Ratio

PB Ratio

2.62
LH price to book ratio is 2.62

PB Ratio Sector Rank

66.72%
LH price to book ratio is higher than 66.72% of companies in Healthcare sector

PS Ratio

PS Ratio

1.62
LH price to sales ratio is 1.62

PS Ratio Sector Rank

34.88%
LH price to sales ratio is higher than 34.88% of companies in Healthcare sector

Enterprise value

Enterprise Value

$26.84 B
LH enterprise value is $26.84 billion

Enterprise Value Sector Rank

96.68%
LH enterprise value is higher than 96.68% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

14.82
LH EV/EBITDA is 14.82

EV/EBITDA Sector Rank

87.6%
LH EV/EBITDA is higher than 87.6% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

1.44
LH annual current ratio is 1.44

Annual Quick Ratio

1.30
LH annual quick ratio is 1.30

Leverage

Annual Debt To Equity

0.79
LH annual debt to equity ratio is 0.79

Annual Interest Coverage Ratio

5.61
LH annual interest coverage ratio is 5.61

Risk & Stability

Piotroski F-Score

7
LH piotroski f-score is 7

Altman Z-Score

2.87
LH altman z-score is 2.87

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$18.38 B
LH annual total assets is $18.38 billion

Annual Non Current Assets

$13.57 B
LH annual long term assets is $13.57 billion

Annual Current Assets

$4.81 B
LH annual total current assets is $4.81 billion

Annual Cash & Cash Equivalents

$1.52 B
LH annual cash & cash equivalents is $1.52 billion

Equity

Annual Book Value

$8.05 B
LH annual book value is $8.05 billion

Annual Working Capital

$1.48 B
LH annual working capital is $1.48 billion

Liabilities

Annual Total Liabilities

$10.31 B
LH annual total liabilities is $10.31 billion

Annual Total Long Term Liabilities

$6.98 B
LH annual total long term liabilities is $6.98 billion

Annual Current Liabilities

$3.33 B
LH annual total current liabilities is $3.33 billion

Annual Accounts Payable

$875.80 M
LH annual accounts payable is $875.80 million

Debt

Annual Total Debt

$7.27 B
LH annual total debt is $7.27 billion

Annual Total Debt 1-Year Change

+22.15%
LH annual total debt is up +22.15% year-on-year

Annual Long Term Debt

$6.08 B
LH annual long term debt is $6.08 billion

Annual Short Term Debt

$1.19 B
LH annual short term debt is $1.19 billion

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$11.87 B
LH annual total expenses is $11.87 billion

Annual Operating Expenses

$2.49 B
LH annual total operating expenses is $2.49 billion

Annual Cost Of Goods Sold

$9.38 B
LH annual cost of goods sold is $9.38 billion

Annual SGA

$2.23 B
LH annual SGA is $2.23 billion

Annual D&A

$643.50 M
LH annual depreciation & amortization is $643.50 million

Annual Interest Expense

$208.30 M
LH annual interest expense is $208.30 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

$1.59 B
LH annual cash flow from operations is $1.59 billion

Annual CFO 1-Year Change

+19.44%
LH annual cash flow from operations is up +19.44% year-on-year

Annual CFI

-$1.37 B
LH annual cash flow from investing activities is -$1.37 billion

Annual CFI 1-Year Change

-16.67%
LH annual cash flow from investing activities is down -16.67% year-on-year

Annual CFF

$779.90 M
LH annual cash flow from financing activities is $779.90 million

Annual CFF 1-Year Change

+1415.18%
LH annual cash flow from financing activities is up +1415.18% year-on-year

Free CashFlow

Annual FCF

$1.10 B
LH annual free cash flow is $1.10 billion

Annual FCF 1-Year Change

+25.37%
LH annual free cash flow is up +25.37% year-on-year

CAPEX

Annual CAPEX

$489.90 M
LH annual capital expenditures is $489.90 million

Annual CAPEX 1-Year Change

+8%
LH annual capital expenditures is up +8% year-on-year

Institutional Ownership

Similar stocks

BIIB logo
Biogen (BIIB)
ZBH logo
Zimmer Biomet Holdings (ZBH)
NTRA logo
Natera (NTRA)
STE logo
STERIS (STE)
WAT logo
Waters (WAT)
DGX logo
Quest Diagnostics Incorporated (DGX)
TEVA logo
Teva Pharmaceutical Industries Limited (TEVA)
PODD logo
Insulet (PODD)
BAX logo
Baxter International (BAX)

FAQ

  • What is the ticker symbol for Laboratory Corporation of America Holdings?
  • Does Laboratory Corporation of America Holdings pay dividends?
  • What sector is Laboratory Corporation of America Holdings in?
  • What industry is Laboratory Corporation of America Holdings in?
  • What country is Laboratory Corporation of America Holdings based in?
  • When did Laboratory Corporation of America Holdings go public?
  • Is Laboratory Corporation of America Holdings in the S&P 500?
  • Is Laboratory Corporation of America Holdings in the NASDAQ 100?
  • Is Laboratory Corporation of America Holdings in the Dow Jones?
  • When was Laboratory Corporation of America Holdings's last earnings report?
  • When does Laboratory Corporation of America Holdings report earnings?
  • Should I buy Laboratory Corporation of America Holdings stock now?

What is the ticker symbol for Laboratory Corporation of America Holdings?

The ticker symbol for Laboratory Corporation of America Holdings is NYSE:LH

Does Laboratory Corporation of America Holdings pay dividends?

Yes, Laboratory Corporation of America Holdings pays dividends. The last payment was $0.72, with an ex-dividend date on November 26, 2024

What sector is Laboratory Corporation of America Holdings in?

Laboratory Corporation of America Holdings is in the Healthcare sector

What industry is Laboratory Corporation of America Holdings in?

Laboratory Corporation of America Holdings is in the Diagnostics & Research industry

What country is Laboratory Corporation of America Holdings based in?

Laboratory Corporation of America Holdings is headquartered in United States

When did Laboratory Corporation of America Holdings go public?

Laboratory Corporation of America Holdings's initial public offering (IPO) was on March 29, 1990

Is Laboratory Corporation of America Holdings in the S&P 500?

Yes, Laboratory Corporation of America Holdings is included in the S&P 500 index

Is Laboratory Corporation of America Holdings in the NASDAQ 100?

No, Laboratory Corporation of America Holdings is not included in the NASDAQ 100 index

Is Laboratory Corporation of America Holdings in the Dow Jones?

No, Laboratory Corporation of America Holdings is not included in the Dow Jones index

When was Laboratory Corporation of America Holdings's last earnings report?

Laboratory Corporation of America Holdings's most recent earnings report was on Feb 6, 2025

When does Laboratory Corporation of America Holdings report earnings?

The next expected earnings date for Laboratory Corporation of America Holdings is Apr 25, 2025

Should I buy Laboratory Corporation of America Holdings stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions